Title Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting
Authors Duan, Cunxian
Zhang, Dianrui
Wang, Feihu
Zheng, Dandan
Jia, Lejiao
Feng, Feifei
Liu, Yue
Wang, Yancai
Tian, Keli
Wang, Fengshan
Zhang, Qiang
Affiliation Shandong Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Jinan 250012, Peoples R China.
Shandong Univ, Sch Med, Inst Biochem & Mol Biol, Jinan 250012, Peoples R China.
Shandong Univ, Sch Pharmaceut Sci, Natl Glycoengn Res Ctr, Jinan 250012, Peoples R China.
Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China.
Shandong Univ, Sch Pharmaceut Sci, Dept Pharmaceut, 44 Wenhua Xilu, Jinan 250012, Peoples R China.
Keywords Nanogels
Chitosan
N-isopropylacrylamide
Tumor extracellular pH
Oridonin
DRUG-DELIVERY
IN-VITRO
N-ISOPROPYLACRYLAMIDE
PH
NANOPARTICLES
MICELLES
CHITOSAN
HYDROGELS
RELEASE
VIVO
Issue Date 2011
Publisher international journal of pharmaceutics
Citation INTERNATIONAL JOURNAL OF PHARMACEUTICS.2011,409,(1-2),252-259.
Abstract The principle objective of this research was to develop and characterize pH-responsive and biocompatible nanogels as a tumor-targeting drug delivery system. The nanogels were self-assembled from chitosan-based copolymers, chitosan-graft-poly(N-isopropylacrylamide) (CS-g-PNIPAm). The copolymers were synthesized via free radical copolymerization and characterized for their chemical structure by FT-IR and (1)H NMR. These copolymers could be efficiently loaded with oridonin (ORI) and the characteristics of ORI-loaded nanogels were evaluated. Drug release researches indicated that the ORI-loaded nanogels displayed pH-dependent release behaviors. Based on MTT assay and cellular morphological analysis, the anti-tumor activity of ORI-loaded nanogels was higher at pH 6.5 than at pH 7.4. In conclusion, the obtained nanogels appeared to be of great promise in tumor extracellular pH targeting for ORI. (C) 2011 Elsevier B.V. All rights reserved.
URI http://hdl.handle.net/20.500.11897/239696
ISSN 0378-5173
DOI 10.1016/j.ijpharm.2011.02.050
Indexed SCI(E)
Appears in Collections: 药学院
天然药物与仿生药物国家重点实验室

Web of Science®


82

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.